Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Canivell S, Mata-Cases M, Vlacho B, Gratacòs M, Real J, Mauricio D, Franch-Nadal J.

J Diabetes Res. 2019 Nov 11;2019:2018374. doi: 10.1155/2019/2018374. eCollection 2019.

2.

Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study.

Mata-Cases M, Franch-Nadal J, Real J, Cedenilla M, Mauricio D.

BMJ Open. 2019 Oct 28;9(10):e031281. doi: 10.1136/bmjopen-2019-031281.

3.

High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study.

Rodríguez-Poncelas A, Franch-Nadal J, Coll-de Tuero G, Mata-Cases M, Alonso-Fernández M, Mur-Marti T, Ruiz A, Giraldez-García C, Regidor E.

PLoS One. 2019 Sep 19;14(9):e0222848. doi: 10.1371/journal.pone.0222848. eCollection 2019.

4.

Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia.

Franch-Nadal J, Mata-Cases M, Ortega E, Real J, Gratacòs M, Vlacho B, Vallés JA, Mauricio D.

J Clin Med. 2019 Sep 5;8(9). pii: E1389. doi: 10.3390/jcm8091389.

5.

Analysis of the location of retinal lesions in central retinographies of patients with Type 2 diabetes.

Munuera-Gifre E, Saez M, Juvinyà-Canals D, Rodríguez-Poncelas A, Barrot-de-la-Puente JF, Franch-Nadal J, Romero-Aroca P, Barceló MA, Coll-de-Tuero G.

Acta Ophthalmol. 2019 Aug 30. doi: 10.1111/aos.14223. [Epub ahead of print]

PMID:
31469507
6.

Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient's perspective. The EnREDa2 Study.

Rodríguez-Fortúnez P, Franch-Nadal J, Fornos-Pérez JA, Martínez-Martínez F, de Paz HD, Orera-Peña ML.

BMJ Open. 2019 Jun 22;9(6):e028467. doi: 10.1136/bmjopen-2018-028467.

7.

Lifestyle factors do not explain the difference on diabetes progression according to type of prediabetes: Results from a Spanish prospective cohort of prediabetic patients.

Ezquerra-Lázaro I, Cea-Soriano L, Giraldez-García C, Ruiz A, Franch-Nadal J, Diez-Espino J, Nogales P, Carramiñana F, Javier Sangros F, Regidor E; PREDAPS Study Group.

Diabetes Res Clin Pract. 2019 Jul;153:66-75. doi: 10.1016/j.diabres.2019.05.033. Epub 2019 May 29.

PMID:
31152806
8.

Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area.

Mata-Cases M, Franch-Nadal J, Ortega E, Real J, Gratacòs M, Vlacho B, Mauricio D.

Curr Med Res Opin. 2019 Oct;35(10):1735-1744. doi: 10.1080/03007995.2019.1618806. Epub 2019 Jun 17.

PMID:
31081693
9.

Ultrasound Tissue Characterization of Carotid Plaques Differs Between Patients with Type 1 Diabetes and Subjects without Diabetes.

Castelblanco E, Betriu À, Hernández M, Granado-Casas M, Ortega E, Soldevila B, Ramírez-Morros A, Franch-Nadal J, Puig-Domingo M, Fernández E, Avogaro A, Alonso N, Mauricio D.

J Clin Med. 2019 Mar 28;8(4). pii: E424. doi: 10.3390/jcm8040424.

10.

Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population: Di@bet.es study.

Valdés S, Doulatram-Gamgaram V, Lago A, García Torres F, Badía-Guillén R, Olveira G, Goday A, Calle-Pascual A, Castaño L, Castell C, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbés J, Gomis R, Ortega E, Galán-García JL, Aguilera-Venegas G, Soriguer F, Rojo-Martínez G.

Eur J Endocrinol. 2019 May 1;180(5):273-280. doi: 10.1530/EJE-18-0818.

PMID:
30840583
11.

Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.

Canivell S, Mata-Cases M, Real J, Franch-Nadal J, Vlacho B, Khunti K, Gratacòs M, Mauricio D.

Diabetes Obes Metab. 2019 Jun;21(6):1373-1380. doi: 10.1111/dom.13663. Epub 2019 Mar 19.

PMID:
30756446
12.

Dairy Product Consumption and Metabolic Diseases in the Di@bet.es Study.

Lago-Sampedro A, García-Escobar E, Rubio-Martín E, Pascual-Aguirre N, Valdés S, Soriguer F, Goday A, Calle-Pascual A, Castell C, Menéndez E, Delgado E, Bordiú E, Castaño L, Franch-Nadal J, Girbés J, Chaves FJ, Gaztambide S, Rojo-Martínez G, Olveira G.

Nutrients. 2019 Jan 24;11(2). pii: E262. doi: 10.3390/nu11020262.

13.

Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study.

Franch-Nadal J, García-Gollarte F, Pérez Del Molino A, Orera-Peña ML, de Miguel MR, Melogno-Klinkas M, de Paz HD, Aceituno S, Rodríguez-Fortúnez P.

Clin Drug Investig. 2019 Jan;39(1):73-84. doi: 10.1007/s40261-018-0713-6.

PMID:
30315498
14.

Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in Spain.

Doria M, Viadé J, Palomera E, Pérez R, Lladó M, Costa E, Huguet T, Reverter JL, Serra-Prat M, Franch-Nadal J, Mauricio D.

Endocrinol Diabetes Nutr. 2018 Nov;65(9):479-485. doi: 10.1016/j.endinu.2018.06.004. Epub 2018 Aug 11. English, Spanish.

PMID:
30108031
15.

Adiposity and Diabetes Risk in Adults with Prediabetes: Heterogeneity of Findings Depending on Age and Anthropometric Measure.

Giráldez-García C, Franch-Nadal J, Sangrós FJ, Ruiz A, Carramiñana F, Goday A, Villaró M, García-Soidán FJ, Serrano R, Regidor E; PREDAPS Study Group.

Obesity (Silver Spring). 2018 Sep;26(9):1481-1490. doi: 10.1002/oby.22256. Epub 2018 Aug 1.

16.

Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.

Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-García C, Mancera J, Goday A, Mundet-Tudurí X, Regidor E; PREDAPS Study Group.

PLoS One. 2018 Jun 1;13(6):e0198327. doi: 10.1371/journal.pone.0198327. eCollection 2018.

17.

Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes.

Carbonell M, Castelblanco E, Valldeperas X, Betriu À, Traveset A, Granado-Casas M, Hernández M, Vázquez F, Martín M, Rubinat E, Lecube A, Franch-Nadal J, Fernández E, Puig-Domingo M, Avogaro A, Alonso N, Mauricio D.

Cardiovasc Diabetol. 2018 May 4;17(1):66. doi: 10.1186/s12933-018-0706-z.

18.

Iron deficiency is associated with Hypothyroxinemia and Hypotriiodothyroninemia in the Spanish general adult population: Di@bet.es study.

Maldonado-Araque C, Valdés S, Lago-Sampedro A, Lillo-Muñoz JA, Garcia-Fuentes E, Perez-Valero V, Gutierrez-Repiso C, Goday A, Urrutia I, Peláez L, Calle-Pascual A, Castaño L, Castell C, Delgado E, Menendez E, Franch-Nadal J, Gaztambide S, Girbés J, Ortega E, Vendrell J, Chacón MR, Chaves FJ, Soriguer F, Rojo-Martínez G.

Sci Rep. 2018 Apr 26;8(1):6571. doi: 10.1038/s41598-018-24352-9.

19.

Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.

Suárez-Ortegón MF, McLachlan S, Price AH, Fernández-Balsells M, Franch-Nadal J, Mata-Cases M, Barrot-de la Puente J, Mundet-Tudurí X, Mauricio D, Ricart W, Wild SH, Strachan MWJ, Price JF, Fernández-Real JM.

Atherosclerosis. 2018 May;272:193-199. doi: 10.1016/j.atherosclerosis.2018.03.028. Epub 2018 Mar 21.

PMID:
29625295
20.

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.

Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, Tangri N, Goh SY, Thuresson M, Chen H, Surmont F, Hammar N, Fenici P; CVD-REAL Investigators and Study Group.

J Am Coll Cardiol. 2018 Jun 12;71(23):2628-2639. doi: 10.1016/j.jacc.2018.03.009. Epub 2018 Mar 11.

Supplemental Content

Loading ...
Support Center